Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents. 2018

Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, Université de Montpellier, CNRS, ENSCM, cc 1705, Site Triolet, Place Eugène Bataillon, 34095, Montpellier cedex 5, France.

The synthesis and the antiviral evaluation of 3'-halo (iodo and fluoro) 5'-norcarbocyclic nucleoside phosphonates is described. No antiviral activity was observed against Zika virus, Dengue virus 2, HSV-1, HSV-2 and Chikungunya virus. In contrast, some of the synthesized compounds are potent inhibitors of the replication of HIV-1, comparatively to (R)-PMPA, with no concomitant cytotoxicity.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D063065 Organophosphonates Carbon-containing phosphonic acid compounds. Included under this heading are compounds that have carbon bound to either OXYGEN atom or the PHOSPHOROUS atom of the (P Phosphonate,Phosphonates,Phosphonic Acid Esters,Acid Esters, Phosphonic,Esters, Phosphonic Acid

Related Publications

Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
January 2015, Nucleosides, nucleotides & nucleic acids,
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
August 2020, Molecules (Basel, Switzerland),
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
March 2019, ChemMedChem,
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
October 2011, Nucleosides, nucleotides & nucleic acids,
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
October 2022, ChemMedChem,
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
September 2019, Molecules (Basel, Switzerland),
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
March 2006, Bioorganic & medicinal chemistry,
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
January 2012, Nucleosides, nucleotides & nucleic acids,
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
September 2011, European journal of medicinal chemistry,
Nadège Hamon, and Malika Kaci, and Jean-Pierre Uttaro, and Christian Périgaud, and Christophe Mathé
December 2007, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!